We are live on
!
Find out more
Regeneron Pharmaceuticals
REGN
REGN
1,079 hedge funds and large institutions have $56.6B invested in Regeneron Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 175 funds opening new positions, 428 increasing their positions, 321 reducing their positions, and 97 closing their positions.
New
Increased
Maintained
Reduced
Closed
80% more first-time investments, than exits
New positions opened: 175 | Existing positions closed: 97
33% more repeat investments, than reductions
Existing positions increased: 428 | Existing positions reduced: 321
6% more funds holding
Funds holding: 1,017 → 1,079 (+62)
4% more capital invested
Capital invested by funds: $54.4B → $56.6B (+$2.25B)
0.66% less ownership
Funds ownership: 86.01% → 85.34% (-0.66%)
12% less funds holding in top 10
Funds holding in top 10: 17 → 15 (-2)
33% less call options, than puts
Call options by funds: $985M | Put options by funds: $1.48B
Holders
1,079
Holders Change
+62
Holders Change %
+6.1%
% of All Funds
16.61%
Holding in Top 10
15
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-11.76%
% of All Funds
0.23%
New
175
Increased
428
Reduced
321
Closed
97
Calls
$985M
Puts
$1.48B
Net Calls
-$492M
Net Calls Change
-$207M
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$301M |
| 2 |
Two Sigma Advisers
New York
|
+$239M |
| 3 |
Two Sigma Investments
New York
|
+$196M |
| 4 |
Dodge & Cox
San Francisco,
California
|
+$172M |
| 5 |
BlackRock
New York
|
+$150M |
